NVN1 (Stavzor 250 mg)
Generic Name: valproic acid
Pill imprint NVN1 has been identified as Stavzor 250 mg.
Stavzor is used in the treatment of epilepsy; schizoaffective disorder; seizure prevention; migraine prevention; mania (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Stavzor 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- valproic acid
- 250 mg
- 14.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine
- CSA Schedule:
- Not a controlled drug
- JDS Pharmaceuticals LLC
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - methyl methacrylate copolymer (1:1)
FD&C Yellow No. 6
More about Stavzor (valproic acid)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.